256 related articles for article (PubMed ID: 17505515)
1. Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium.
Blaheta RA; Michaelis M; Natsheh I; Hasenberg C; Weich E; Relja B; Jonas D; Doerr HW; Cinatl J
Br J Cancer; 2007 Jun; 96(11):1699-706. PubMed ID: 17505515
[TBL] [Abstract][Full Text] [Related]
2. Chemoresistance induces enhanced adhesion and transendothelial penetration of neuroblastoma cells by down-regulating NCAM surface expression.
Blaheta RA; Daher FH; Michaelis M; Hasenberg C; Weich EM; Jonas D; Kotchetkov R; Doerr HW; Cinatl J
BMC Cancer; 2006 Dec; 6():294. PubMed ID: 17181871
[TBL] [Abstract][Full Text] [Related]
3. Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model.
Kotchetkov R; Cinatl J; Blaheta R; Vogel JU; Karaskova J; Squire J; Hernáiz Driever P; Klingebiel T; Cinatl J
Int J Cancer; 2003 Mar; 104(1):36-43. PubMed ID: 12532417
[TBL] [Abstract][Full Text] [Related]
4. Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression.
Kotchetkov R; Driever PH; Cinatl J; Michaelis M; Karaskova J; Blaheta R; Squire JA; Von Deimling A; Moog J; Cinatl J
Int J Oncol; 2005 Oct; 27(4):1029-37. PubMed ID: 16142320
[TBL] [Abstract][Full Text] [Related]
5. Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization.
Bedrnicek J; Vicha A; Jarosova M; Holzerova M; Cinatl J; Michaelis M; Cinatl J; Eckschlager T
Neoplasma; 2005; 52(5):415-9. PubMed ID: 16151587
[TBL] [Abstract][Full Text] [Related]
6. Human cytomegalovirus infection of tumor cells downregulates NCAM (CD56): a novel mechanism for virus-induced tumor invasiveness.
Blaheta RA; Beecken WD; Engl T; Jonas D; Oppermann E; Hundemer M; Doerr HW; Scholz M; Cinatl J
Neoplasia; 2004; 6(4):323-31. PubMed ID: 15256054
[TBL] [Abstract][Full Text] [Related]
7. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
[TBL] [Abstract][Full Text] [Related]
8. The ability in adhesion and invasion of drug-resistant human glioma cells.
Hikawa T; Mori T; Abe T; Hori S
J Exp Clin Cancer Res; 2000 Sep; 19(3):357-62. PubMed ID: 11144529
[TBL] [Abstract][Full Text] [Related]
9. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells.
Cinatl J; Cinatl J; Vogel JU; Kotchetkov R; Driever PH; Kabickova H; Kornhuber B; Schwabe D; Doerr HW
Cancer Res; 1998 Jan; 58(2):367-72. PubMed ID: 9443419
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid and interferon-alpha synergistically inhibit neuroblastoma cell growth in vitro and in vivo.
Michaelis M; Suhan T; Cinatl J; Driever PH; Cinatl J
Int J Oncol; 2004 Dec; 25(6):1795-9. PubMed ID: 15547719
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid modulates NCAM polysialylation and polysialyltransferase mRNA expression in human tumor cells.
Beecken WD; Engl T; Ogbomo H; Relja B; Cinatl J; Bereiter-Hahn J; Oppermann E; Jonas D; Blaheta RA
Int Immunopharmacol; 2005 Apr; 5(4):757-69. PubMed ID: 15710344
[TBL] [Abstract][Full Text] [Related]
12. Expulsion of amplified MYCN from homogenously staining chromosomal regions in neuroblastoma cell lines after cultivation with cisplatin, doxorubicin, hydroxyurea, and vincristine.
Prochazka P; Hrabeta J; Vícha A; Eckschlager T
Cancer Genet Cytogenet; 2010 Jan; 196(1):96-104. PubMed ID: 19963143
[TBL] [Abstract][Full Text] [Related]
13. Altered cell-cell adhesion in cisplatin-resistant human carcinoma cells: a link between beta-catenin/plakoglobin ratio and cisplatin resistance.
Cimbora-Zovko T; Ambriović-Ristov A; Loncarek J; Osmak M
Eur J Pharmacol; 2007 Mar; 558(1-3):27-36. PubMed ID: 17234182
[TBL] [Abstract][Full Text] [Related]
14. Bovine seminal ribonuclease exerts selective cytotoxicity toward neuroblastoma cells both sensitive and resistant to chemotherapeutic drugs.
Cinatl J; Cinatl J; Kotchetkov R; Matousek J; Woodcock BG; Koehl U; Vogel JU; Kornhuber B; Schwabe D
Anticancer Res; 2000; 20(2A):853-9. PubMed ID: 10810366
[TBL] [Abstract][Full Text] [Related]
15. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
Groh T; Hrabeta J; Poljakova J; Eckschlager T; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():16-24. PubMed ID: 23353839
[TBL] [Abstract][Full Text] [Related]
16. Expression level of neural cell adhesion molecule (NCAM) inversely correlates with the ability of neuroblastoma cells to adhere to endothelium in vitro.
Blaheta RA; Hundemer M; Mayer G; Vogel JU; Kornhuber B; Cinatl J; Markus BH; Driever PH; Cinatl J
Cell Commun Adhes; 2002; 9(3):131-47. PubMed ID: 12521134
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
[TBL] [Abstract][Full Text] [Related]
18. Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha.
Cinatl J; Kotchetkov R; Blaheta R; Driever PH; Vogel JU; Cinatl J
Int J Oncol; 2002 Jan; 20(1):97-106. PubMed ID: 11743648
[TBL] [Abstract][Full Text] [Related]
19. [Cytomegalovirus infection as a possible factor in the progression of neuroblastoma].
Scholz M; Blaheta RA; Hundemer M; Doerr HW; Cinatl J
Klin Padiatr; 1999; 211(4):310-3. PubMed ID: 10472568
[TBL] [Abstract][Full Text] [Related]
20. DFF45/ICAD restores cisplatin-induced nuclear fragmentation but not DNA cleavage in DFF45-deficient neuroblastoma cells.
Takahashi M; Ozaki T; Takahashi A; Miyauchi M; Ono S; Takada N; Koda T; Todo S; Kamijo T; Nakagawara A
Oncogene; 2007 Aug; 26(38):5669-73. PubMed ID: 17353905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
